The following drugs have been rejected by the Scottish Medicines Consortium (SMC) for use within NHS Scotland, as a result of absent or insufficient submissions from manufacturers:
- Rupatadine (Rupafin) for allergic rhinitis and chronic idiopathic urticaria.
- Ketoprofen/omeprazole (Axorid) for rheumatoid arthritis, ankylosing spondylitis and osteoarthritis in patients with a history or risk of NSAID-associated gastrointestinal ulceration or erosion.
- Extended-release epidural morphine (Depodur) for relief of post-operative pain following major orthopaedic, abdominal or pelvic surgery.
The drugs may be subject to re-appraisal.